Molly Harper sold $385K of Catalyst Pharmaceuticals (CPRX)

Executed Nov 27 2024, disclosed Nov 29 2024, 2 days later.

Value, as filed

$385K

17,500 sh × $22.00

Executed

Nov 27 2024

the trade date, as filed

Disclosed

Nov 29 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MH Molly Harper Director profile →

Molly Harper (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in CPRX. The largest single filing was $622K of CPRX (26,746 sh across 3 lots, as filed), executed Dec 12 2025.

The name

CPRX CPRX CPRX · 20 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Molly Harper in CPRX

CPRXSALE CATALYST PHARMACEUTICALS, INC. $622K
26,746 sh across 3 lots
Exec Dec 12 2025
Filed Dec 16 2025 · 5:30 PM ET